This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.
Identification
- Brand Names
- Menopur
- Generic Name
- Luteinizing hormone
- DrugBank Accession Number
- DB14741
- Background
Not Available
- Type
- Biotech
- Groups
- Approved
- Biologic Classification
- Protein Based Therapies
Hormones - Protein Chemical Formula
- Not Available
- Protein Average Weight
- Not Available
- Sequences
- Not Available
- Synonyms
- Gonadotropin, luteinizing hormone
- LH
- Luteinising hormone
- Luteinising hormone (human)
- Luteinizing gonadotropic hormone
- Luteinizing hormone
- Luteotropic hormone
- Pituitary luteinizing hormone
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Associated Conditions
- Associated Therapies
- Contraindications & Blackbox Warnings
Avoid life-threatening adverse drug eventsImprove clinical decision support with information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events & improve clinical decision support.- Pharmacodynamics
Not Available
- Mechanism of action
- Not Available
- Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates.Improve decision support & research outcomes with our structured adverse effects data.- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- No interactions found.
Products
Drug product information from 10+ global regionsOur datasets provide approved product information including:dosage, form, labeller, route of administration, and marketing period.Access drug product information from over 10 global regions.- Mixture Products
Name Ingredients Dosage Route Labeller Marketing Start Marketing End Region Image Humegon Inj 75 I.U. Luteinizing hormone (75 unit / kit) + Follitropin (75 unit / kit) + Sodium chloride (.9 % / kit) Liquid; Powder, for solution Intramuscular Organon Canada Ltd Ltee 1993-12-31 2006-08-17 Canada 
MENOGON 75 IU LIYOFILIZE TOZ ICEREN AMPUL,5 ADET Luteinizing hormone (75 iu) + Follitropin (75 iu) Injection, powder, lyophilized, for solution Intramuscular; Subcutaneous FERRİNG İLAÇ SAN. VE TİC. LTD. ŞTİ. 2020-08-14 2021-10-20 Turkey 
Menopur Luteinizing hormone (75 [iU]/1) + Follitropin (75 [iU]/1) + Sodium chloride (9 mg/1) Injection Subcutaneous Ferring Pharmaceuticals Inc. 2004-10-29 Not applicable US 
MENOPUR 1200 IU MULTI DOZ ICIN SC ENJEKSIYONLUK COZELTI TOZU ICEREN FLAKON VE KULLANIMA HAZIR ENJEKTORDE COZUCU (1 ADET FLAKON + 2 ADET KULLANIMA HAZIR ENJEKTOR) Luteinizing hormone (1200 iu/1ml) + Follitropin (1200 iu/1ml) Injection, powder, lyophilized, for solution Subcutaneous FERRİNG İLAÇ SAN. VE TİC. LTD. ŞTİ. 2020-08-14 Not applicable Turkey MENOPUR 150 IU IM VE SC ENJEKSIYON IÇIN TOZ IÇEREN FLAKON, 1 ADET Luteinizing hormone (150 iu) + Follitropin (150 iu) Injection, powder, lyophilized, for solution Intramuscular; Subcutaneous FERRİNG İLAÇ SAN. VE TİC. LTD. ŞTİ. 2020-08-14 Not applicable Turkey MENOPUR 150 IU IM VE SC ENJEKSIYON IÇIN TOZ IÇEREN FLAKON, 10 ADET Luteinizing hormone (150 iu) + Follitropin (150 iu) Injection, powder, lyophilized, for solution Intramuscular; Subcutaneous FERRİNG İLAÇ SAN. VE TİC. LTD. ŞTİ. 2020-08-14 Not applicable Turkey MENOPUR 150 IU IM VE SC ENJEKSIYON IÇIN TOZ IÇEREN FLAKON, 5 ADET Luteinizing hormone (150 iu) + Follitropin (150 iu) Injection, powder, lyophilized, for solution Intramuscular; Subcutaneous FERRİNG İLAÇ SAN. VE TİC. LTD. ŞTİ. 2020-08-14 Not applicable Turkey MENOPUR 600 IU MULTI DOZ ICIN SC ENJEKSIYONLUK COZELTI TOZU ICEREN FLAKON VE KULLANIMA HAZIR ENJEKTORDE COZUCU (1 ADET FLAKON + 1 ADET KULLANIMA HAZIR ENJEKTOR) Luteinizing hormone (600 iu/1ml) + Follitropin (600 iu/1ml) Injection, powder, lyophilized, for solution Subcutaneous FERRİNG İLAÇ SAN. VE TİC. LTD. ŞTİ. 2020-08-14 Not applicable Turkey MENOPUR 75 IU IM VE SC ENJEKSIYON ICIN TOZ ICEREN FLAKON, 5 ADET Luteinizing hormone (75 iu) + Follitropin (75 iu) Injection, powder, lyophilized, for solution Intramuscular; Subcutaneous FERRİNG İLAÇ SAN. VE TİC. LTD. ŞTİ. 2020-08-14 Not applicable Turkey Pergonal 75 I.U. Luteinizing hormone (75 unit / amp) + Follitropin (75 unit / amp) Powder, for solution Intramuscular Emd Serono, A Division Of Emd Inc., Canada 1979-12-31 2007-05-07 Canada
Categories
- Drug Categories
- Chemical TaxonomyProvided by Classyfire
- Description
- Not Available
- Kingdom
- Organic Compounds
- Super Class
- Organic Acids
- Class
- Carboxylic Acids and Derivatives
- Sub Class
- Amino Acids, Peptides, and Analogues
- Direct Parent
- Peptides
- Alternative Parents
- Not Available
- Substituents
- Not Available
- Molecular Framework
- Not Available
- External Descriptors
- Not Available
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- 8XA4VN1LH4
- CAS number
- 9002-67-9
References
- General References
- Not Available
- External Links
- 6383
- Wikipedia
- Luteinizing_hormone
Clinical Trials
- Clinical Trials
Phase Status Purpose Conditions Count 4 Completed Basic Science Controlled Ovarian Stimulation / Infertility 1 4 Completed Other Cardiovascular Disease (CVD) / Neoplasms of the Prostate 1 4 Completed Treatment In Vitro Fertilization (IVF) / Infertility 1 4 Completed Treatment Pregnancy 1 4 Terminated Treatment Idiopathic Hypogonadotropic Hypogonadism 1 4 Unknown Status Treatment Female Infertility 1 4 Unknown Status Treatment Infertility 1 3 Completed Treatment Hypogonadism 1 3 Completed Treatment Infertility / Ovarian Stimulation 1 3 Completed Treatment Ovarian Stimulation 1
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
Form Route Strength Liquid; powder, for solution Intramuscular Injection Subcutaneous Injection, powder, for solution Intramuscular; Subcutaneous Injection, powder, lyophilized, for solution Subcutaneous Injection, powder, lyophilized, for solution Intramuscular; Subcutaneous Powder, for solution Intramuscular Kit Intramuscular; Subcutaneous - Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Not Available
- Experimental Properties
- Not Available
Drug created at February 27, 2019 23:25 / Updated at August 17, 2021 04:17